NYU WINTHROP HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $4.9M
- Transactions
- 1,208
- Companies
- 40
- Average per transaction
- $4,019
Who reported the payments
| Merck | $924,544 |
| Pfizer | $482,810 |
| AstraZeneca | $397,221 |
| Edwards Lifesciences | $365,946 |
| Janssen Research & Development, LLC | $329,412 |
| Soleno Therapeutics, Inc. | $298,188 |
| Eli Lilly | $287,054 |
| E.r. Squibb & Sons, L.L.C. | $201,328 |
| Novo Nordisk AS | $192,002 |
| Olympus Corporation Of The Americas | $179,363 |
| Shire North American Group Inc | $164,073 |
| Novo Nordisk | $98,261 |
| Acell, Inc. | $83,196 |
| Abbott | $82,171 |
| Actelion Pharmaceuticals, Ltd | $64,665 |
| AbbVie | $45,345 |
| Incyte Corporation | $44,380 |
| Procept Biorobotics Corporation | $41,933 |
| Lumendi LLC | $38,125 |
| MDD US Operations, LLC | $36,894 |
| Bayer | $34,044 |
| Medtronic | $28,224 |
| Smith+Nephew | $25,935 |
| Boston Scientific | $25,705 |
| Actelion Pharmaceuticals US, Inc. | $23,822 |
| Aesculap, Inc. | $22,840 |
| Apollo Endosurgery US Inc | $19,051 |
| Sanofi | $18,759 |
| Covidien LP | $18,500 |
| ERBE USA Inc | $18,500 |
| Angiodynamics, Inc. | $17,693 |
| Akebia Therapeutics Inc | $16,920 |
| Medical Device Business Services, Inc. | $15,194 |
| Novartis | $13,551 |
| Olympus America Inc. | $12,861 |
| Chiesi USA, Inc. | $12,670 |
| Takeda Pharmaceuticals U.S.A., Inc. | $12,286 |
| GSK | $11,623 |
| OPKO Pharmaceuticals, LLC | $11,580 |
| Insulet Corporation | $10,625 |